Page last updated: 2024-08-24

adibendan and Heart Failure

adibendan has been researched along with Heart Failure in 4 studies

*Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. [MeSH]

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
England, PJ; Murray, KJ1
Dietz, R; Haass, M; Kapp, M; Kübler, W; Neumann, FJ; Rauch, B; Smolarz, A; Tillmanns, H; Von Molitor, S; Zimmermann, R1
May, E; Peters, P; Saborowski, F; Schneider, M1
Karsch, KR; Mauser, M; Preisack, M; Voelker, W1

Reviews

1 review(s) available for adibendan and Heart Failure

ArticleYear
Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.
    Biochemical Society transactions, 1992, Volume: 20, Issue:2

    Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Benzimidazoles; Dihydropyridines; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoenzymes; Milrinone; Oxindoles; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Vasodilator Agents

1992

Other Studies

3 other study(ies) available for adibendan and Heart Failure

ArticleYear
Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failure.
    Clinical cardiology, 1991, Volume: 14, Issue:5

    Topics: Adult; Benzimidazoles; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Male; Middle Aged; Neurosecretory Systems; Oxindoles; Phosphodiesterase Inhibitors

1991
[Central hemodynamics of a new positive inotropic substance, adibendan. Data from a dose-finding study].
    Arzneimittel-Forschung, 1990, Volume: 40, Issue:6

    Topics: Aged; Benzimidazoles; Blood Pressure; Cardiac Output; Chronic Disease; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Oxindoles; Pulmonary Circulation; Stroke Volume; Vasodilator Agents

1990
Acute hemodynamic effects of adibendan, a new phosphodiesterase inhibitor, for severe congestive heart failure.
    The American journal of cardiology, 1989, Aug-01, Volume: 64, Issue:5

    Topics: Benzimidazoles; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Oxindoles; Phosphodiesterase Inhibitors; Random Allocation; Vasodilator Agents

1989